AzTrials
AzTrials

Deep CariesR2NCT04607395

Pre-operative Radiograph of Deep Carious Lesions as a Predictive Tool for Pulpal Exposure

An observational study of Deep Caries, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Preserving pulpal vitality is a major challenge when excavating deep caries lesions without severe symptomatology. Pulpal exposure alters success of the treatment (dropping from 93% for indirect pulp treatment with selective excavation to 11% for direct pulpotomy) and thus prognosis of dental organ and… Read more about this study

Who is it for?
Ages 8 to 80 years
Conditions the study is for
Deep Caries
What is being tested?
pre-operative radiograph
Type of treatment
Surgery or procedure
How many people
358 participants
Where
1 siteFrance
Study dates
1 Feb 2015to 1 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 80 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: pre-operative radiographs of deep carious lesions treated with DECAT

Who may be able to join

  • -pre-operative radiographs of deep carious lesions treated with DECAT protocole, unless they were out of the study.

Who cannot join

  • Impossibility to assess carious lesion on radiograph, and amalgam restorations that impairs correct examination of carious lesion
  • Radiographs of poor quality and screen captures

Trial locations and contacts

1 site in 1 country.

France1 site
  • Professeur des Universités- Praticien Hospitalier

    Lyon, 69008

Other trials in France

About this study

Official title: Pre-operative Radiograph of Deep Carious Lesions as a Predictive Tool for Pulpal Exposure.

Preserving pulpal vitality is a major challenge when excavating deep caries lesions without severe symptomatology. Pulpal exposure alters success of the treatment (dropping from 93% for indirect pulp treatment with selective excavation to 11% for direct pulpotomy) and thus prognosis of dental organ and cost-effectiveness of the treatment. The preoperative x-ray is a complementary examination which allows to estimate the depth of the carious lesion. In clinical practice, it is currently difficult to accurately measure this depth on preoperative radiographs. This lack of precision leads to a decrease in the effective capacity of the operator to predict the risk of pulpal exposure. Their interpretation is considered imprecise and is not used as a diagnostic element.

The aim of this study was to determine if the use of pre-operative retroalveolar radiographs can help to predict pulpal exposure risk.

Conditions
Deep Caries
Being tested
pre-operative radiograph

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pre-operative radiographRadiation

    Three hundred and sixty pre-operative radiographs of deep carious lesions and a "contrasted" version of the same set have been screened and annotated by 4 evaluators. Annotations were placed at the dentino-enamel junction, at the floor of the carious lesions, and on pulp chamber wall. From these annotations, the ratios residual dentin thickness/ total dentin thickness were derived. First, inter-evaluator agreement and concordance were assessed. A logistic regression that accounted for measurement error was applied to precisely estimate the capacity of the ratio to predict exposure (reported as odds-ratio).

Study groups in NCT04607395
Study groupRoleWhat they receive
pre-operative radiographs of deep carious lesionNot described
Receives: Radiation: pre-operative radiograph

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of residual dentin thickness and total dentin thickness on standard pre-operative radiographs

    The radiographic assessment consisted in determining the depth of each carious lesion from the pre-operative radiographs and from their contrasted version. In this work, the depth of one carious lesion was measured by the ratio (expressed in percent): 100*residual dentin thickness (RDT)/ Total dentin thickness (TDT). A logistic regression that accounted for measurement error was applied to precisely estimate the capacity of the ratio to predict exposure (reported as odds-ratio).

    Measured: Outcome measure was assessed trough study completion, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2020
  2. Study start1 Feb 2015
  3. Primary completion1 Aug 2017
  4. Study completion1 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
358 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04607395
Sponsor's protocol ID
R2_2020
Acronym
R2
Status last verified
Jul 2020
First submitted
23 Jul 2020
Last updated
29 Oct 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Gasqui MA, Perard M, Decup F, Monsarrat P, Turpin YL, Villat C, Gueyffier F, Maucort-Boulch D, Roche L, Grosgogeat B. Place of a new radiological index in predicting pulp exposure before intervention for deep carious lesions. Oral Radiol. 2022 Jan;38(1):89-98. doi: 10.1007/s11282-021-00530-w. Epub 2021 May 5.

    PubMed 33954908

Questions about this trial

What is this clinical trial studying?

An observational study of Deep Caries, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of residual dentin thickness and total dentin thickness on standard pre-operative radiographs (time frame: Outcome measure was assessed trough study completion, an average of 1 year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04607395, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in